Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine

Antigenic cross-reactivity between certain tumours has allowed the development of more widely applicable, major histocompatibility complex-disparate (allogeneic) whole-cell vaccines. This principle should also allow heat shock proteins (hsp) derived from certain tumours (and carrying cross-reactive...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Casey, David G, Lysaght, Joanne, James, Tharappel, Bateman, Andrew, Melcher, Alan A, Todryk, Stephen M
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2003
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1783031/
https://ncbi.nlm.nih.gov/pubmed/12941147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2567.2003.01726.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky